PerioChip®

A biodegradable periodontal chip releasing 2.5mg Chlorhexidine Gluconate over a period of 10 days

Novel OTC formulation

Novel Formulation of a well-known US OTC Brand

Omeprazole DR Tablets

Proprietary Delayed Release Tablet Formulation of Omeprazole OTC

Complex Injectable
(Co-development)

Complex injectable product equivalent to a well-known brand in the oncology field; Co-developed with CSPC Pharma

ViePax® XR
(Venlafaxine XR tablets)

Proprietary Extended Release Tablet formulation bioequivalent to capsule Effexor XR capsules

Dexcel in numbers
2
new chemical entities in development
1000+
employees
3
manufacturing plants
300
marketing authorizations
5B+
tablets produced per year
47
years in operation
>10%
of sales invested annually in R&D
39
distribution countries
20+
Gx products in development
67
unique products
14
505(b)(2) products in development
68
patent & patent applications